tiprankstipranks
Bicara Therapeutics Inc. (BCAX)
NASDAQ:BCAX
US Market
BCAX
Bicara Therapeutics Inc.
RESEARCH TOOLSreports

Bicara Therapeutics Inc. (BCAX) Income Statement

77 Followers

Bicara Therapeutics Inc. Income Statement

Last quarter (Q4 2025), Bicara Therapeutics Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Bicara Therapeutics Inc.'s net income was $-37.39M. See Bicara Therapeutics Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 155.60M$ 82.39M$ 39.89M$ 37.66M
Depreciation and Amortization
$ 105.00K$ 56.00K$ 19.00K$ 10.00K
EBITDA
$ -155.60M$ -82.33M$ -39.87M$ -37.72M
Operating Income
$ -155.60M$ -82.39M$ -39.89M$ -37.66M
Other Income/Expenses
$ 17.87M$ 14.58M$ -12.09M$ -188.00K
Pretax Income
$ -137.73M$ -67.81M$ -51.98M$ -37.84M
Net Income
$ -137.95M$ -68.00M$ -51.98M$ -37.84M
Per Share Metrics
Basic EPS
$ -2.52$ -1.25$ -1.00$ -0.73
Diluted EPS
$ -2.52$ -1.25$ -1.00$ -0.73
Weighted Average Shares Outstanding
 54.68M 54.42M 51.76M 51.76M
Weighted Average Shares Outstanding (Diluted)
 54.68M 54.42M 51.76M 51.76M
Currency in USD

Bicara Therapeutics Inc. Earnings and Revenue History